166 related articles for article (PubMed ID: 23195013)
1. Chronic renal failure complications and management in kidney transplanted and nontransplanted patients.
Kaysi S; Hadj Abdelkader M; Aniort J; Garrouste C; Philipponnet C; Deteix P; Heng AE
Transplant Proc; 2012 Dec; 44(10):2997-3000. PubMed ID: 23195013
[TBL] [Abstract][Full Text] [Related]
2. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?
Jiménez Alvaro S; Marcén R; Teruel JL; Fernández Rodríguez A; Pascual J; Galeano C; Villacorta J; Burgos FJ; Ortuño J
Transplant Proc; 2009; 41(6):2409-11. PubMed ID: 19715935
[TBL] [Abstract][Full Text] [Related]
3. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
[TBL] [Abstract][Full Text] [Related]
4. Assessment of nonimmunologic factors in kidney transplant recipients according to Kidney Disease Improving Global Outcomes.
Dounousi E; Mitsis M; Spanos G; Pappas C; Koutlas V; Tzalavra I; Xarisis C; Glantzounis G; Fatouros M; Siamopoulos KC
Transplant Proc; 2012 Nov; 44(9):2709-11. PubMed ID: 23146500
[TBL] [Abstract][Full Text] [Related]
5. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
[TBL] [Abstract][Full Text] [Related]
6. Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
Shastri J; Tran A; Covit A; Pepe J; Sherman RA
J Ren Nutr; 2008 Jul; 18(4):370-4. PubMed ID: 18558302
[TBL] [Abstract][Full Text] [Related]
7. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
Wazny LD; Raymond CB; Lesperance EM; Bernstein KN
CANNT J; 2008; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
[TBL] [Abstract][Full Text] [Related]
8. Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohort.
Cozzolino M; Messa P; Brancaccio D; Cannella G; Bolasco P; Di Luca M; Costanzo AM; Paparatti Ud; Festa V; Gualberti G; Mazzaferro S;
Blood Purif; 2014; 38(1):37-45. PubMed ID: 25277167
[TBL] [Abstract][Full Text] [Related]
9. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
Panawong W; Chaiyakum A; Pongskul C
J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
[TBL] [Abstract][Full Text] [Related]
10. The MAURO study: baseline characteristics and compliance with guidelines targets.
Leonardis D; Mallamaci F; Enia G; Postorino M; Tripepi G; Zoccali C;
J Nephrol; 2012; 25(6):1081-90. PubMed ID: 23172127
[TBL] [Abstract][Full Text] [Related]
11. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
[TBL] [Abstract][Full Text] [Related]
12. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
13. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
Uribarri J;
Semin Dial; 2004; 17(5):349-50. PubMed ID: 15461740
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and complications of chronic kidney disease in paediatric renal transplantation: a K/DOQI perspective.
Sinha R; Saad A; Marks SD
Nephrol Dial Transplant; 2010 Apr; 25(4):1313-20. PubMed ID: 19926719
[TBL] [Abstract][Full Text] [Related]
15. Relevance of chronic kidney disease classification (K/DOQI) in renal transplant patients.
Fernandez-Fresnedo G; de Francisco A; Ruiz JC; Cotorruelo JG; Alamillo CG; Valero R; Castañeda O; Zalduendo B; Izquierdo MJ; Arias M
Transplant Proc; 2006 Oct; 38(8):2402-3. PubMed ID: 17097948
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a chronic kidney disease clinic in achieving K/DOQI guideline targets at initiation of dialysis--a single-centre experience.
Lee W; Campoy S; Smits G; Vu Tran Z; Chonchol M
Nephrol Dial Transplant; 2007 Mar; 22(3):833-8. PubMed ID: 17127695
[TBL] [Abstract][Full Text] [Related]
17. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
Ravera M; Paoletti E
Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
[TBL] [Abstract][Full Text] [Related]
18. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
[TBL] [Abstract][Full Text] [Related]
19. Adherence to K/DOQI bone metabolism guidelines.
Smith DH; Johnson ES; Thorp ML; Yang X
J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
[TBL] [Abstract][Full Text] [Related]
20. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.
Collins AJ; Brenner RM; Ofman JJ; Chi EM; Stuccio-White N; Krishnan M; Solid C; Ofsthun NJ; Lazarus JM
Am J Kidney Dis; 2005 Sep; 46(3):481-8. PubMed ID: 16129210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
